Why the study?
Can post-stress NT-proBNP levels predict diastolic heart failure in asymptomatic hypertensives with microvascular disease?
Can post-stress NT-proBNP levels predict diastolic heart failure in asymptomatic hypertensives with microvascular disease?
Post-stress NT-proBNP measurement during stress ECG may help identify early-stage diastolic heart failure in asymptomatic hypertensive patients with microvascular disease.
Post-stress NT-proBNP elevation was associated with diastolic dysfunction in hypertensives; leaves open its value for predicting heart failure progression.
The utility of N-terminal pro brain natriuretic peptide (NT-proBNP) for detecting a diastolic heart failure (HF) in hypertensives is unclear. We investigated the relation between post-stress concentration of NT-proBNP and left ventricular diastolic HF in asymptomatic hypertensives with microvascular disease. 122 (82 females, 68%, age 46–65 years, mean age 55.2 ± 8.6 years) ambulatory adequately-controlled hypertensives with microvascular disease (ischemic ST segment changes on stress electrocardiography (SECG) but normal coronary angiography, and negative myocardial perfusion scintigraphy). Color M-Mode was used for the identification of the diastolic dysfunction, that was determed as a ratio of early peak diastolic transmitral E wave velocity to intraventricular flow propagation velocity Vp (data suggest that E/Vp>2.5 correlates with significant diastolic HF). NT-proBNP level measured within 5 minutes in the recovery period of SECG was used as a biomarker of HF. Patients with E/Vp<2.5 (n=82) had a mean post-stress NT-proBNP concentration of 326 ± 84 ng/l (level within the normal range); those with E/Vp>2.5 (n = 40) had a significantly elevated mean post-stress NT-proBNP level of 986 ± 96 ng/l (p < 0.05). The assessment of the blood concentration of NT-proBNP in a rapid assay during SECG in asymptomatic hypertensives with microvascular disease might be of potential value for identification of those with early stage of diastolic HF.
No takes yet. Share an insight, caveat, or question.
Kisko et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: